Boardroom Alpha
Start trial
8-K primary document
FEED · Current Report (Form 8-K) · Filed December 12, 2025

Envue Medical Inc — 8-K exhibit

ex3-1.htm
Envue Medical Inc on Boardroom Alpha

 

Exhibit 3.1

 

Certificate of Amendment

of

Certificate of Incorporation

of

NANOVIBRONIX, INC.

 

NanoVibronix, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”) hereby certifies:

 

1.The date of filing the original Certificate of Incorporation of this Corporation with the Secretary of State of the State of Delaware was October 20, 2003.
   
2.The date of filing of the Amended and Restated Certificate of Incorporation of this Corporation with the Secretary of State of the State of Delaware was April 10, 2015.
   
3.The Amended and Restated Certificate of Incorporation was further amended by Certificates of Amendment to the Amended and Restated Certificate of Incorporation, filed with the Secretary of State of Delaware on November 20, 2019, August 17, 2021, February 7, 2023, March 12, 2025, and August 8, 2025.
   
4.Resolutions were duly adopted by the Board of Directors of the Corporation setting forth this proposed amendment to the Certificate of Incorporation.
   
5.Article FIRST of the Certificate of Incorporation is hereby amended and restated in its entirety to read as follows:

 

“The name of the corporation is ENvue Medical, Inc. (hereinafter referred to as the “Corporation”).

 

6.The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
   
7.The effective date of this Certificate of Amendment to the Certificate of Incorporation shall be December 12, 2025.

 

[Signature page follows.]

 

 

 

 

IN WITNESS WHEREOF, said corporation has caused this Certificate of Amendment to be executed this 8th day of December, 2025.

 

  NANOVIBRONIX, Inc.
     
  By: /s/ Doron Besser, M.D.
  Name: Doron Besser, M.D.
  Title: Chief Executive Officer

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer